Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $500.43 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $154.64 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $107.09 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $51.59 | 3 | $0 (2024) |
| Genentech USA, Inc. | $47.33 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $46.44 | 1 | $0 (2021) |
| Ethicon Inc. | $43.45 | 1 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $25.85 | 1 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $24.04 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.09 | 6 | GENZYME CORPORATION ($53.31) |
| 2023 | $192.59 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($107.09) |
| 2022 | $75.01 | 3 | GENZYME CORPORATION ($61.44) |
| 2021 | $87.74 | 3 | Regeneron Healthcare Solutions, Inc. ($46.44) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Cardiology | ||||||
| 12/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $43.45 | General |
| Category: Endo-Mechanical | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Immunology | ||||||
| 05/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Immunology | ||||||
| 11/30/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Immunology | ||||||
| 07/20/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $24.44 | General |
| 06/29/2023 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: BioOncology | ||||||
| 05/30/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 03/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $107.09 | General |
| 12/01/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Respiratory | ||||||
| 05/10/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.53 | General |
| Category: Immunology | ||||||
| 04/14/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Immunology | ||||||
| 12/15/2021 | VERTEX PHARMACEUTICALS INCORPORATED | TRIKAFTA (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 10/21/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/25/2021 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $15.45 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 172 | 230 | $47,514 | $15,785 |
| 2022 | 3 | 147 | 194 | $44,841 | $15,116 |
| 2021 | 7 | 240 | 317 | $62,369 | $21,783 |
| 2020 | 4 | 160 | 197 | $43,168 | $14,169 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 50 | $10,850 | $3,815 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 33 | $9,602 | $3,460 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 42 | $9,247 | $3,122 | 33.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $9,840 | $2,710 | 27.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 34 | $5,202 | $1,721 | 33.1% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 16 | 47 | $2,773 | $956.71 | 34.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 54 | 91 | $19,383 | $6,214 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 67 | $14,874 | $4,994 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 36 | $10,584 | $3,907 | 36.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 68 | 128 | $27,012 | $8,870 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 66 | $14,528 | $5,483 | 37.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 31 | $9,044 | $3,743 | 41.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 29 | $4,308 | $1,398 | 32.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 23 | $3,457 | $1,214 | 35.1% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 17 | 19 | $2,030 | $689.58 | 34.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 19 | 21 | $1,990 | $384.40 | 19.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 61 | 92 | $19,080 | $6,561 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 55 | $11,898 | $3,635 | 30.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 34 | 35 | $10,000 | $3,232 | 32.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 15 | $2,190 | $740.85 | 33.8% |
About Daniel Gritters, NP
Daniel Gritters, NP is a Registered Nurse healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1205249414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Gritters, NP has received a total of $500.43 in payments from pharmaceutical and medical device companies, with $145.09 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($500.43).
As a Medicare-enrolled provider, Gritters has provided services to 719 Medicare beneficiaries, totaling 938 services with total Medicare billing of $66,853. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Grand Rapids, MI
- Active Since 06/05/2014
- Last Updated 03/04/2021
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1205249414
Products in Payments
- DUPIXENT (Biological) $161.19
- Monarch Platform (Device) $43.45
- Xolair (Biological) $27.42
- TRIKAFTA (Drug) $25.85
- FASENRA (Biological) $24.29
- OPSUMIT (Drug) $24.04
- Tecentriq (Biological) $19.91
- BREZTRI (Drug) $13.73
- TEZSPIRE (Biological) $13.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Grand Rapids
Leah Magnuson, Np, NP
Registered Nurse — Payments: $4,112
Mackenzie Swanson, Dnp, DNP
Registered Nurse — Payments: $2,669
Jessica Andrina, Cpnp-Ac, CPNP-AC
Registered Nurse — Payments: $1,451
Mrs. Ashley Strotbaum, Rn-Bsn, Pa, RN-BSN, PA
Registered Nurse — Payments: $836.64
Michelle Vandentoorn
Registered Nurse — Payments: $782.91
Mallorie Bleka, Fnp, Dnp, FNP, DNP
Registered Nurse — Payments: $706.03